FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to pharmaceutical compositions having improved stability, for use in treating or preventing uterine atony conditions, excessive bleeding, postpartum haemorrhage (PPH).
EFFECT: disclosed is a pharmaceutical composition.
11 cl, 9 ex, 7 tbl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
ORALLY DISINTEGRATING SOLID PHARMACEUTICAL DOSAGE UNIT CONTAINING PARTUS CONTROL SUBSTANCE | 2015 |
|
RU2701199C2 |
ORALLY DISINTEGRATING SOLID PHARMACEUTICAL DOSAGE UNIT CONTAINING A GENERIC ACTIVITY CONTROLLING SUBSTANCE | 2015 |
|
RU2719416C2 |
PHARMACEUTICAL PREPARATION CONTAINING EGF RECEPTOR ANTIBODY | 2004 |
|
RU2381036C2 |
COMPOSITIONS CONTAINING ANAKINRA | 2016 |
|
RU2728795C2 |
PHARMACEUTICAL PREPARATIVE FORM | 2004 |
|
RU2362560C2 |
OXYTOCIN ANALOGUES | 2009 |
|
RU2496788C2 |
COMPOSITION OF STABILIZED GROWTH HORMONE AND METHOD OF ITS PREPARING | 1997 |
|
RU2191029C2 |
GROWTH HORMONE-CONTAINING COMPOSITIONS | 2000 |
|
RU2298415C2 |
PHARMACEUTICAL COMPOSITION CONTAINING PALANOSETRON AS AN ACTIVE INGREDIENT | 2017 |
|
RU2732407C1 |
Authors
Dates
2020-11-26—Published
2011-09-29—Filed